Literature DB >> 14614593

Hydrogen peroxide modulates the Kv1.5 channel expressed in a mammalian cell line.

David Caouette1, Christiane Dongmo, Jocelyn Bérubé, Dominique Fournier, Pascal Daleau.   

Abstract

Reactive oxygen species have been implicated in different types of cardiac arrhythmias including human atrial fibrillation. Kv1.5, the presumed molecular correlate of I(Kur), is an important determinant of human atrial repolarization. The aim of this study was to assess the effects of H(2)O(2), at pathophysiologically relevant concentrations (20-1,000 microM), on Kv1.5 expressed in Chinese hamster ovary cell line. Kv1.5 cDNA in pcDNA3 expression vector and CD8, a surface marker protein, were cotransfected in cells by calcium phosphate precipitation. Kv1.5 activation kinetics were significantly accelerated while the activation curve was negatively shifted by 10 mV (V(1/2) changed from -9.3 to -19.0 mV) in the presence of 100 microM H(2)O(2). The shift in Kv1.5 peak current I-V curve was voltage-dependent, the current amplitude being increased for voltages <+20 mV but decreased for high depolarizing voltages. The rapid activation time constant obtained from a bi-exponential fitting was decreased from 16.1+/-3.4 ms to 8.8+/-1.5 ms for a -20 mV depolarization ( n=9; P=0.01) and from 4.3+/-2.1 ms to 2.3+/-0.4 ms when cells were depolarized to +20 mV ( P<0.05). Kv1.5 steady-state inactivation was not modified by H(2)O(2). Intracellular application of SOD or catalase reduced the H(2)O(2) induced shift of activation I-V curve and SOD significantly decreased Kv1.5 amplitude at +40 mV ( n=9; P<0.05). In conclusion, H(2)O(2) increased Kv1.5 current amplitude at voltages corresponding to the action potential repolarization phase and accelerated Kv1.5 channel opening. These changes can reduce the action potential duration, leading to a shortening of the atrial effective refractory period. H(2)O(2)-induced changes in Kv1.5 properties could thus be involved in initiation or perpetuation of AF.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14614593     DOI: 10.1007/s00210-003-0834-0

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  35 in total

1.  Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation.

Authors:  M J Mihm; F Yu; C A Carnes; P J Reiser; P M McCarthy; D R Van Wagoner; J A Bauer
Journal:  Circulation       Date:  2001-07-10       Impact factor: 29.690

2.  Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation.

Authors:  L Yue; J Feng; R Gaspo; G R Li; Z Wang; S Nattel
Journal:  Circ Res       Date:  1997-10       Impact factor: 17.367

3.  Modification of cardiac beta-adrenoceptor mechanisms by H2O2.

Authors:  S Persad; H Rupp; R Jindal; J Arneja; N S Dhalla
Journal:  Am J Physiol       Date:  1998-02

Review 4.  Structure and function of cardiac sodium and potassium channels.

Authors:  D M Roden; A L George
Journal:  Am J Physiol       Date:  1997-08

5.  Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy.

Authors:  P B Garlick; M J Davies; D J Hearse; T F Slater
Journal:  Circ Res       Date:  1987-11       Impact factor: 17.367

6.  Heteromultimeric Kv1.2-Kv1.5 channels underlie 4-aminopyridine-sensitive delayed rectifier K(+) current of rabbit vascular myocytes.

Authors:  P M Kerr; O Clément-Chomienne; K S Thorneloe; T T Chen; K Ishii; D P Sontag; M P Walsh; W C Cole
Journal:  Circ Res       Date:  2001-11-23       Impact factor: 17.367

7.  Abnormal electrical activity induced by free radical generating systems in isolated cardiocytes.

Authors:  P L Barrington; C F Meier; W B Weglicki
Journal:  J Mol Cell Cardiol       Date:  1988-12       Impact factor: 5.000

8.  Modulation of K+ channels by hydrogen peroxide.

Authors:  E Vega-Saenz de Miera; B Rudy
Journal:  Biochem Biophys Res Commun       Date:  1992-08-14       Impact factor: 3.575

9.  Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats.

Authors:  M C Wijffels; C J Kirchhof; R Dorland; M A Allessie
Journal:  Circulation       Date:  1995-10-01       Impact factor: 29.690

10.  Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications.

Authors:  W M Feinberg; J L Blackshear; A Laupacis; R Kronmal; R G Hart
Journal:  Arch Intern Med       Date:  1995-03-13
View more
  22 in total

1.  Oxidative modification of M-type K(+) channels as a mechanism of cytoprotective neuronal silencing.

Authors:  Nikita Gamper; Oleg Zaika; Yang Li; Pamela Martin; Ciria C Hernandez; Michael R Perez; Andrew Y C Wang; David B Jaffe; Mark S Shapiro
Journal:  EMBO J       Date:  2006-10-05       Impact factor: 11.598

2.  Electrophysiological characterization of three non-synonymous single nucleotide polymorphisms (R87Q, A251T, and P307S) found in hKv1.5.

Authors:  Isabelle Plante; Dominique Fournier; Guylaine Ricard; Benoît Drolet; Gilles O'Hara; Jean Champagne; Patrick Mathieu; Richard Baillot; Pascal Daleau
Journal:  Pflugers Arch       Date:  2006-01-13       Impact factor: 3.657

3.  Hypoxamirs and mitochondrial metabolism.

Authors:  Katherine A Cottrill; Stephen Y Chan; Joseph Loscalzo
Journal:  Antioxid Redox Signal       Date:  2014-02-03       Impact factor: 8.401

4.  Reactive oxygen species scavengers improve voltage-gated K(+) channel function in pulmonary arteries of newborn pigs with progressive hypoxia-induced pulmonary hypertension.

Authors:  Candice D Fike; Judy L Aschner; Mark R Kaplowitz; Yongmei Zhang; Jane A Madden
Journal:  Pulm Circ       Date:  2013-11-20       Impact factor: 3.017

5.  Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension.

Authors:  M Sean McMurtry; Stephen L Archer; Dario C Altieri; Sebastien Bonnet; Alois Haromy; Gwyneth Harry; Sandra Bonnet; Lakshmi Puttagunta; Evangelos D Michelakis
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

Review 6.  The renin-angiotensin-aldosterone system (RAAS) and cardiac arrhythmias.

Authors:  Shahriar Iravanian; Samuel C Dudley
Journal:  Heart Rhythm       Date:  2008-03-04       Impact factor: 6.343

7.  A pilot study to estimate the feasibility of assessing the relationships between polymorphisms in hKv1.5 and atrial fibrillation in patients following coronary artery bypass graft surgery.

Authors:  Isabelle Plante; Dominique Fournier; Patrick Mathieu; Pascal Daleau
Journal:  Can J Cardiol       Date:  2008-01       Impact factor: 5.223

Review 8.  Coronary microvascular Kv1 channels as regulatory sensors of intracellular pyridine nucleotide redox potential.

Authors:  Marc M Dwenger; Vahagn Ohanyan; Manuel F Navedo; Matthew A Nystoriak
Journal:  Microcirculation       Date:  2018-01       Impact factor: 2.628

9.  Palmitate attenuates myocardial contractility through augmentation of repolarizing Kv currents.

Authors:  Todd E Haim; Wei Wang; Thomas P Flagg; Michael A Tones; Anthony Bahinski; Randal E Numann; Colin G Nichols; Jeanne M Nerbonne
Journal:  J Mol Cell Cardiol       Date:  2009-10-24       Impact factor: 5.000

10.  Characterization of a novel multifunctional resveratrol derivative for the treatment of atrial fibrillation.

Authors:  Istvan Baczko; David Liknes; Wei Yang; Kevin C Hamming; Gavin Searle; Kristian Jaeger; Zoltan Husti; Viktor Juhasz; Gergely Klausz; Robert Pap; Laszlo Saghy; Andras Varro; Vernon Dolinsky; Shaohua Wang; Vivek Rauniyar; Dennis Hall; Jason Rb Dyck; Peter E Light
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.